🇺🇸 FDA
Patent

US 10683272

Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy

granted A61KA61K49/0002A61K49/106

Quick answer

US patent 10683272 (Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy) held by Northwestern University expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K49/0002, A61K49/106, A61K49/108, A61K49/12